Preprint
Epigenetic Modulation, Intra-tumoral Microbiome and Immunity in Early Onset Colorectal Cancer
bioRxiv
Cold Spring Harbor Laboratory, 1.1
04/02/2025
DOI: 10.1101/2025.03.28.645992
PMCID: PMC11996295
PMID: 40236026
Abstract
The incidence of colorectal cancer (CRC) in young adults (age of diagnosis < 50 years old) has been rapidly increasing. Although ∼20% of early-onset (EO) CRC cases are due to germline mutations, the etiology of the majority of EOCRC cases remains poorly understood. Non-genetic factors such as environmental exposure and lifestyle changes are likely to have a direct link to the increased incidence of sporadic EOCRC. We hypothesize that such factors may be observable as differences in the EOCRC epigenome, microbiome and immunome. We sought to address this by comparing differences in DNA methylation from the cohort of colorectal cancer patients in The Cancer Genome Atlas (TCGA). Further, we carefully identified intra-tumoral microbes from TCGA and two other datasets and then related the microbes to EOCRC status and deconvolved immune cell abundances. We found that DNA methylation (DNAm) age acceleration by12 years when compared with average-onset CRC (AOCRC) patients. Differentially methylated sites associated with genes are related to CREB signaling in neurons, G protein coupled receptor signaling, phagosome formation and S100 family signaling. These differences were validated in the gene expression from TCGA and a second, larger real-world dataset from the Oncology Research Information Exchange Network (ORIEN). However, no consistent differences were observed in the intra-tumor microbes between EOCRC and AOCRC. Interestingly, the most abundant microbes interacted with the immune systems differently between the EOCRC and AOCRC tumors, characterized by more, larger, positive correlations in EOCRC. These data suggest epigenetic modulation and accelerated aging may play a key role in the development of EOCRC.
We investigated whether environmentally driven factors contribute to early-onset colorectal cancer (EOCRC). We observed accelerated epigenetic aging in EOCRC and epigenetic changes associated with chronic inflammation. Tumor immune cell abundances correlated more strongly with microbes in EOCRC than average-onset CRC. These data suggest a dysregulation of immune response in EOCRC, driving chronic inflammation and tissue aging.
Details
- Title: Subtitle
- Epigenetic Modulation, Intra-tumoral Microbiome and Immunity in Early Onset Colorectal Cancer
- Creators
- Ning Jin - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteRebecca Hoyd - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteAyse Selen Yilmaz - The Ohio State UniversityJiangjiang Zhu - The Ohio State UniversityYunzhou Liu - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteMalvenderjit Jagjit Singh - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteDennis Grencewicz - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteXiaoKui Mo - The Ohio State UniversityMatthew Kalady - The Ohio State UniversityDaniel Rosenberg - University of ConnecticutCaroline E Dravillas - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteEric A Singer - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteJohn D Carpten - Department of Translational Genomics, University of Southern CaliforniaCarlos HF Chan - University of Iowa, SurgeryMichelle L ChurchmanNicholas C Denko - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteFrances Di Clemente - Rutgers Cancer InstituteRebecca D Dodd - University of IowaIslam Eljilany - Moffitt Cancer CenterNaomi Fei - University of IowaSheetal Hardikar - University of UtahAlexandra P Ikeguchi - University of OklahomaAnjun Ma - The Ohio State UniversityQin Ma - The Ohio State UniversityMartin D McCarter - Department of Surgery, University of Colorado School of MedicineAfaf EG Osman - University of UtahGregory Riedlinger - Rutgers Cancer InstituteLary A Robinson - Moffitt Cancer CenterBryan P Schneider - Indiana UniversityAhmad A Tarhini - Moffitt Cancer CenterGabriel Tinoco - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteJane Figueiredo - Cedars-Sinai Medical CenterYousef Zakharia - University of IowaCornelia M Ulrich - University of UtahAik Choon Tan - University of UtahDaniel Spakowicz - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- Resource Type
- Preprint
- Publication Details
- bioRxiv
- Edition
- 1.1
- DOI
- 10.1101/2025.03.28.645992
- PMID
- 40236026
- PMCID
- PMC11996295
- NLM abbreviation
- bioRxiv
- ISSN
- 2692-8205
- eISSN
- 2692-8205
- Publisher
- Cold Spring Harbor Laboratory
- Number of pages
- 36
- Language
- English
- Date posted
- 04/02/2025
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Surgery; Radiation Oncology; Internal Medicine
- Record Identifier
- 9984810950402771
Metrics
19 Record Views